Glucuronidation of prodrug reactive site: Isolation and characterization of oxymethylglucuronide metabolite of fosphenytoin

Clinical Chemistry

Volumn 47, Issue 5, 2001, Pages 910-918

  Annesley, T M ^a   Kurzyniec, S ^a   Nordblom, G D ^a   Buchanan, N ^a   Pool, W ^a   Reily, M ^a   Talaat, R ^a   Roberts, W L ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBENE; DEUTERIUM; DRUG METABOLITE; FOSPHENYTOIN SODIUM; GLUCURONIC ACID; GLUCURONIDE; ORGANOPHOSPHATE; OXYMETHYLGLUCURONIDE; PHENYL GROUP; PHENYTOIN; PRODRUG; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE STUDY; DRUG DETERMINATION; DRUG GLUCURONIDATION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; MASS FRAGMENTOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SOLID PHASE EXTRACTION; STRUCTURE ANALYSIS; TANDEM MASS SPECTROMETRY; UREMIA;

EID: 0035043098     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.5.910     Document Type: Article

References (28)

1. Development, synthesis, and biological evaluation of (-)trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5- (3-hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate ester
2. Intracellular metabolism of cyclosaligenyl 3′-azido-2′,3′-dideoxythymidine monophosphate, a prodrug of 3′-azido-2′,3′-dideoxythymidine (zidovudine)
3. A risk-benefit assessment of amifostine in cytoprotection
4. Antineoplastic agents 389. New synthesis of the combrestatin A-4 prodrug
5. The oral fluorouracil prodrugs
6. Etoposide phosphate, the water soluble prodrug of etoposide
7. Water-soluble combinations of dexanabinol: Prodrugs and analogs
8. Development of anti-influenza virus drugs I: Improvement of oral absorption and in vivo anti-influenza activity of stachyflin and its derivatives
9. Metronidazole phosphate - A water soluble prodrug for parenteral solutions of metronidazole
10. Synthesis of a water-soluble prodrug of entacapone
11. Pharmacokinetics and safety of a phenytoin prodrug given IV of IM in patients
12. In vitro hydrolysis of ACC-9653 (phosphate ester prodrug of phenytoin) by human, dog, and rat blood and tissues
13. Falsely increased immunoassay measurements of total and unbound phenytoin in critically ill uremic patients receiving fosphenytoin
14. Simultaneous rapid high-performance liquid chromatographic determination of phenytoin and its prodrug, fosphenytoin in human plasma and ultrafiltrate
15. Cross-reactivity of fosphenytoin in two human plasma phenytoin immunoassays
16. Evaluation of the Cobas Integra free phenytoin immunoassay
17. Preparation of metabolites of imipramine and phenytoin
18. UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoin
19. Hydantoin ring glucuronidation: Characterization of a new metabolite of 5,5-diphenylhydantoin in man and rat
20. Usefulness of the hydrogendeuterium exchange method in the study of drug metabolism using liquid chromatography-tandem mass spectrometry
21. Synthesis and biological evaluation of a water soluble phosphate prodrug of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP)
22. Phosphoryloxymethyl carbamates and carbonates - Novel water-soluble prodrugs for amines and hindered alcohols
23. Enhancement of oral bioavailability of phenytoin by esterification, and in vitro hydrolytic characteristics of prodrugs
24. Acyloxymethyl as a drug protecting group. Part 7. Tertiary sulfonamidomethyl ester prodrugs of benzylpenicillin: Chemical hydrolysis and antibacterial activity
25. Acyloxymethyl as a drug protecting group. Part 6. N-Acyloxymethyl- and N-[(aminocarbonyloxy)methyl]-sulfonamides as prodrugs of agents containing a secondary sulfonamide group
26. Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil
27. Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil